Welcome to the
Hepatitis B Foundation
Drug-Resistant Hepatitis B Virus: Still a Major Issue in Europe
Aug 24 – The largest study ever conducted on drug resistance in patients infected with Hepatitis B in Europe shows that half of patients in whom HBV is not fully suppressed by treatment harbor the drug-resistant virus. This is because doctors in Europe are still prescribing old antiviral drugs, which may also cause resistance to modern compounds. Read more.
People With Hepatitis B Can Safely Use Truvada PrEP for HIV Prevention
Aug 24 – People with hepatitis B virus did not experience liver inflammation 'flares' or other adverse events when they used or stopped using Truvada for HIV pre-exposure prophylaxis (PrEP), according to an analysis from the iPrEx study. Read more.
Bionic Liver Micro-Organs Explain Off-Target Toxicity of Acetaminophen
Aug 24 – The development of a liver-on-a-chip device, including nanotechnology-based sensors that mimic human physiology, may lead to critical models to predict drug toxicity of the liver. Read more.
Multi-National Group of Scientists Developing New Test for Hepatocellular Carcinoma
Aug 24 – A group of clinicians and geochemists are working to develop a test for hepatocellular carcinoma based on methods used to measure the stable isotope compositions of rocks and minerals. Read more.
Antiviral Research Articles Explore Cutting-Edge Treatments That Could Lead to a Cure
In recognition of the 50th anniversary of the discovery of the hepatitis B virus, the journal Antiviral Research has published a series of free articles entitled Hepatitis B: A Wave of New Therapies on the Horizon. The special collection, which explores new drug targets, compounds and experimental strategies to eradicate hepatitis B, was compiled by Dr. Timothy Block and leading scientists of the Baruch S. Blumberg Institute. Read or download the articles for free.
June 2015 - Learn more about HBV and earn CME credits as well! This educational webinar is a collaborative effort between CME Outfitter LLC, ProPatient LLC, and the Hepatitis B Foundation. Download now.
Blumberg Institute Assembles Team of 'All-Star Researchers' to Cure Hepatitis B
April 2015– The Baruch S. Blumberg Institute has recruited a new team of nationally renowned, “all Star researchers” who will focus exclusively on developing a cure for hepatitis B, with a goal for breakthrough therapies within the next three years. Read more.
Page last modified August 24, 2015